RiverFront Investment Group’s iShares US Medical Devices ETF IHI Stock Holding History

RiverFront Investment Group’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.7M	Sell	419,481 -17,889	-4%	-$908K	0.27%	62
2026 Q1	$23.3M	Buy	437,370 +18,748	+4%	+$1.1M	0.36%	56
2025 Q4	$26M	Buy	418,622 +15,790	+4%	+$975K	0.43%	50
2025 Q3	$24.3M	Buy	402,832 +15,200	+4%	+$930K	0.43%	51
2025 Q2	$24.3M	Buy	387,632 +13,664	+4%	+$821K	0.47%	49
2025 Q1	$22.5M	Buy	373,968 +31,951	+9%	+$1.98M	0.5%	47
2024 Q4	$20M	Buy	342,017 +24,068	+8%	+$1.43M	0.45%	49
2024 Q3	$18.8M	Buy	317,949 +27,120	+9%	+$1.55M	0.44%	51
2024 Q2	$16.3M	Buy	290,829 +23,162	+9%	+$1.3M	0.43%	49
2024 Q1	$15.7M	Buy	267,667 +25,366	+10%	+$1.43M	0.44%	46
2023 Q4	$13.1M	Buy	242,301 +11,823	+5%	+$578K	0.41%	47
2023 Q3	$11.2M	Buy	230,478 +8,957	+4%	+$476K	0.4%	44
2023 Q2	$12.5M	Buy	221,521 +9,173	+4%	+$505K	0.41%	46
2023 Q1	$11.5M	Buy	212,348 +5,098	+2%	+$271K	0.4%	42
2022 Q4	$1.67M	Sell	207,250 -47,914	-19%	-$2.43M	0.38%	51
2022 Q3	$12.6M	Sell	255,164 -25,036	-9%	-$1.3M	0.47%	42
2022 Q2	$14.1M	Buy	280,200 +52,904	+23%	+$2.88M	0.53%	42
2022 Q1	$13.9M	Buy	227,296 +23,359	+11%	+$1.39M	0.44%	42
2021 Q4	$13.4M	Buy	203,937 +12,038	+6%	+$771K	0.42%	42
2021 Q3	$12M	Sell	191,899 -235,373	-55%	-$15M	0.4%	39
2021 Q2	$25.7M	Sell	427,272 -6,180	-1%	-$357K	0.52%	41
2021 Q1	$23.9M	Sell	433,452 -6,156	-1%	-$341K	0.5%	41
2020 Q4	$24M	Sell	439,608 -9,078	-2%	-$475K	0.53%	39
2020 Q3	$22.4M	Sell	448,686 -13,440	-3%	-$651K	0.53%	34
2020 Q2	$20.4M	Sell	462,126 -1,350	-0.3%	-$57.7K	0.5%	37
2020 Q1	$15.5M	Sell	463,476 -14,286	-3%	-$602K	0.6%	31
2019 Q4	$21M	Sell	477,762 -16,500	-3%	-$694K	0.51%	37
2019 Q3	$20.4M	Sell	494,262 -14,058	-3%	-$576K	0.5%	36
2019 Q2	$20.4M	Sell	508,320 -15,228	-3%	-$576K	0.51%	38
2019 Q1	$20.2M	Sell	523,548 -10,014	-2%	-$364K	0.5%	39
2018 Q4	$17.8M	Buy	+533,562	New	+$18.5M	0.48%	43

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

RiverFront Investment Group's IHI Position: Q2 2026 in Review

RiverFront Investment Group reduced its iShares US Medical Devices ETF (IHI) stake by 4.1% in Q2 2026, selling an estimated $908K and leaving 419,481 shares worth $20.7M. The position accounts for 0.27% of the portfolio, ranked #62.

RiverFront Investment Group first reported a position in IHI in Q4 2018 and has held it in 31 quarters since. The position peaked at $26M in Q4 2025. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

RiverFront Investment Group held 419,481 shares of iShares US Medical Devices ETF worth $20.7M as of Q2 2026.
RiverFront Investment Group sold 17,889 iShares US Medical Devices ETF shares in Q2 2026, an estimated $908K.
iShares US Medical Devices ETF made up 0.27% of RiverFront Investment Group's portfolio in Q2 2026, its #62 holding.
RiverFront Investment Group first reported a position in iShares US Medical Devices ETF in Q4 2018 and has held it in 31 quarters since.
RiverFront Investment Group's iShares US Medical Devices ETF position peaked at $26M in Q4 2025.
501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on RiverFront Investment Group's 13F filing for Q2 2026, filed 29 Jul 2026.